Insider Transactions in Q1 2023 at Cidara Therapeutics, Inc. (CDTX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2023
|
Jeffrey Stein President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
271,750
+18.43%
|
-
|
|
Mar 27
2023
|
Shane Ward COO & CLO |
BUY
Grant, award, or other acquisition
|
Direct |
126,667
+37.49%
|
-
|
|
Mar 27
2023
|
Leslie Tari CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+24.31%
|
-
|
|
Mar 27
2023
|
Taylor Sandison Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+19.21%
|
-
|
|
Mar 27
2023
|
Preetam Shah Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+27.43%
|
-
|
|
Mar 27
2023
|
Jeffrey Stein President & CEO |
BUY
Open market or private purchase
|
Indirect |
50,000
+15.08%
|
$50,000
$1.04 P/Share
|
|
Mar 13
2023
|
Taylor Sandison Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,203
-2.44%
|
$7,203
$1.53 P/Share
|
|
Mar 13
2023
|
Preetam Shah Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,648
-4.29%
|
$6,648
$1.53 P/Share
|
|
Mar 13
2023
|
Leslie Tari CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
7,562
-3.82%
|
$7,562
$1.53 P/Share
|
|
Mar 13
2023
|
Shane Ward COO & CLO |
SELL
Open market or private sale
|
Direct |
4,329
-4.87%
|
$4,329
$1.53 P/Share
|
|
Jan 12
2023
|
Leslie Tari CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
11,814
-88.84%
|
$11,814
$1.2 P/Share
|